author-photo

Bart A. van de Wiel

Netherlands Cancer Institute

36

Papers

894

Citations

Citation Trend

Filter By

Papers (27) Sort By

Journal Conference Others

Pathological response and survival with neoadjuvant therapy in melanoma: a pooled analysis from the International Neoadjuvant Melanoma Consortium (INMC).

2021 Nature Medicine
Show All
- Source
- Cite
- Save
Citations (29)
Neoadjuvant Cytoreductive Treatment with BRAF/MEK Inhibition of prior Unresectable Regionally Advanced Melanoma to Allow Complete Surgical Resection, REDUCTOR: A Prospective, Single Arm, Open-label Phase II Trial.

2021 Annals of Surgery
Show All
- Source
- Cite
- Save
Citations (1)
T-VEC for stage IIIB-IVM1a melanoma achieves high rates of complete and durable responses and is associated with tumor load: a clinical prediction model.

2021 Cancer Immunology, Immunotherapy
Show All
- Source
- Cite
- Save
Citations (2)
Rate of complete and durable responses of intralesional therapy with talimogene laherparepvec for stage IIIB-IVM1a melanoma and association with tumor load.

2020 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Phase Ib/II trial testing combined radiofrequency ablation and ipilimumab in uveal melanoma (SECIRA-UM)

2020 Melanoma Research
Show All
- Source
- Cite
- Save
Citations (16)
First safety and efficacy results of PRADO: A phase II study of personalized response-driven surgery and adjuvant therapy after neoadjuvant ipilimumab (IPI) and nivolumab (NIVO) in resectable stage III melanoma.

2020 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (23)
SOX10 is as specific as S100 protein in detecting metastases of melanoma in lymph nodes and is recommended for sentinel lymph node assessment

2020 European Journal of Cancer
Show All
- Source
- Cite
- Save
Citations (4)
Twenty-four months RFS and updated toxicity data from OpACIN-neo: A study to identify the optimal dosing schedule of neoadjuvant ipilimumab (IPI) and nivolumab (NIVO) in stage III melanoma.

2020 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (10)
Challenges in sentinel node pathology in the era of adjuvant treatment.

2020 Journal of Surgical Oncology
Show All
- Source
- Cite
- Save
Citations (2)
Neoadjuvant cytoreductive treatment with BRAF/MEK inhibition of prior unresectable regionally advanced melanoma to allow complete surgical resection: REDUCTOR trial.

2019 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (3)